Healthcare provider profile · identity verified

Michael T Hancock, ARNP

Nurse Practitioner · SPRING HILL, FL · NPI 1083641070

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	140
Levothyroxine Sodium	Levothyroxine Sodium	457	121
Rosuvastatin Calcium	Rosuvastatin Calcium	383	110
Amlodipine Besylate	Amlodipine Besylate	376	107
Losartan Potassium	Losartan Potassium	358	105
Metoprolol Succinate	Metoprolol Succinate	256	64
Lisinopril	Lisinopril	254	66
Omeprazole	Omeprazole	211	50
Atenolol	Atenolol	186	50
Metformin Hcl	Metformin Hcl	186	54
Pantoprazole Sodium	Pantoprazole Sodium	184	54
Famotidine	Famotidine	180	59
Simvastatin	Simvastatin	175	47
Furosemide	Furosemide	164	57
Ozempic	Semaglutide	162	30
Montelukast Sodium	Montelukast Sodium	151	40
Escitalopram Oxalate	Escitalopram Oxalate	143	40
Gabapentin	Gabapentin	132	42
Synthroid	Levothyroxine Sodium	125	30
Potassium Chloride	Potassium Chloride	124	41
Meloxicam	Meloxicam	123	47
Metoprolol Tartrate	Metoprolol Tartrate	115	44
Tamsulosin Hcl	Tamsulosin Hcl	115	33
Hydrochlorothiazide	Hydrochlorothiazide	111	39
Fluticasone Propionate	Fluticasone Propionate	109	43
Clopidogrel	Clopidogrel Bisulfate	106	30
Allopurinol	Allopurinol	101	23
Eliquis	Apixaban	96	22
Alprazolam	Alprazolam	95	39
Ramipril	Ramipril	90	26
Duloxetine Hcl	Duloxetine Hcl	89	25
Carvedilol	Carvedilol	79	22
Methylprednisolone	Methylprednisolone	77	64
Trulicity	Dulaglutide	77	12
Trazodone Hcl	Trazodone Hcl	74	26
Albuterol Sulfate Hfa	Albuterol Sulfate	73	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	20
Pravastatin Sodium	Pravastatin Sodium	67	16
Jardiance	Empagliflozin	66	16
Ezetimibe	Ezetimibe	64	22
Azithromycin	Azithromycin	62	52
Bupropion Xl	Bupropion Hcl	62	16
Finasteride	Finasteride	58	17
Glipizide Er	Glipizide	55	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	55	21
Sertraline Hcl	Sertraline Hcl	55	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	11
Venlafaxine Hcl Er	Venlafaxine Hcl	47	13
Fluoxetine Hcl	Fluoxetine Hcl	45	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	11
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	40	12
Olmesartan Medoxomil	Olmesartan Medoxomil	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	18
Tresiba Flextouch U-100	Insulin Degludec	39	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	38	13
Farxiga	Dapagliflozin Propanediol	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	11
Buspirone Hcl	Buspirone Hcl	34	11
Glimepiride	Glimepiride	34	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	25
Bisoprolol Fumarate	Bisoprolol Fumarate	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	13
Mounjaro	Tirzepatide	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	11
Telmisartan	Telmisartan	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Folic Acid	Folic Acid	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Vascepa	Icosapent Ethyl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	18
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	13
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Mupirocin	Mupirocin	18	16
Prednisone	Prednisone	18	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	17
Baclofen	Baclofen	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clonidine	Clonidine	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Digoxin	Digoxin	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Amoxicillin	Amoxicillin	12	12
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error